Renaissance Capital’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.8M Sell
60,436
-8,734
-13% -$1.24M 8.53% 4
2025
Q4
$11.5M Sell
69,170
-11,956
-15% -$2M 8.29% 4
2025
Q3
$15.9M Sell
81,126
-45,497
-36% -$7.48M 8.9% 3
2025
Q2
$11.4M Sell
126,623
-18,998
-13% -$1.5M 7.98% 4
2025
Q1
$8.69M Buy
145,621
+31,345
+27% +$2.9M 6.71% 4
2024
Q4
$15.1M Buy
114,276
+90,516
+381% +$8.49M 9.93% 2
2024
Q3
$1.24M Buy
23,760
+3,967
+20% +$186K 0.82% 26
2024
Q2
$1.2M Buy
+19,793
New +$1.37M 0.67% 32

Other funds holding ALAB

Renaissance Capital's ALAB Position: Q1 2026 in Review

Renaissance Capital reduced its Astera Labs (ALAB) stake by 13% in Q1 2026, selling an estimated $1.24M and leaving 60,436 shares worth $11.8M. The position accounts for 8.53% of the portfolio, ranked #4.

Renaissance Capital first reported a position in ALAB in Q2 2024 and has held it in 8 quarters since. The position peaked at $15.9M in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Renaissance Capital held 60,436 shares of Astera Labs worth $11.8M as of Q1 2026.
  • Renaissance Capital sold 8,734 Astera Labs shares in Q1 2026, an estimated $1.24M.
  • Astera Labs made up 8.53% of Renaissance Capital's portfolio in Q1 2026, its #4 holding.
  • Renaissance Capital first reported a position in Astera Labs in Q2 2024 and has held it in 8 quarters since.
  • Renaissance Capital's Astera Labs position peaked at $15.9M in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Renaissance Capital's 13F filing for Q1 2026, filed 7 May 2026.